Stryker PE Ratio 2006-2018 | SYK

Current and historical PE ratio for Stryker (SYK) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Stryker (SYK) as of March 31, 2018 is 25.84.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $119.518B 18.50
Abbott Laboratories (ABT) United States $111.818B 23.45
Boston Scientific (BSX) United States $46.527B 25.94
Baxter (BAX) United States $40.022B 28.64
Zimmer Biomet Holdings (ZBH) United States $22.815B 14.37
ResMed (RMD) United States $15.531B 32.48
Smith & Nephew SNATS (SNN) United Kingdom $15.356B 0.00
Perrigo (PRGO) Ireland $10.500B 14.72
Bio-Rad Laboratories (BIO) United States $9.132B 73.65
Hill-Rom Holdings (HRC) United States $6.219B 22.34
ICU Medical (ICUI) United States $6.169B 57.40
Canopy Growth (CGC) Canada $5.511B 0.00
Agios Pharmaceuticals (AGIO) United States $5.252B 0.00
Insulet (PODD) United States $5.222B 0.00
Haemonetics (HAE) United States $5.160B 53.14
Hutchison China MediTech (HCM) China $4.366B 0.00
Neogen (NEOG) United States $4.219B 67.46
GW Pharmaceuticals (GWPH) United Kingdom $4.127B 0.00
National Vision Holdings (EYE) United States $3.044B 0.00
NuVasive (NUVA) United States $2.767B 27.97
Quidel (QDEL) United States $2.615B 114.44
Abaxis,Inc (ABAX) United States $1.905B 64.07
Phibro Animal Health (PAHC) United States $1.899B 28.20
NxStage Medical (NXTM) United States $1.821B 0.00
VAREX IMAGING (VREX) United States $1.447B 22.29
Eagle Pharmaceuticals (EGRX) United States $1.244B 34.80
Cardiovascular Systems (CSII) United States $1.184B 0.00
Orthofix (OFIX) $1.110B 33.82
Owens & Minor (OMI) United States $1.080B 10.86
OraSure Technologies (OSUR) United States $1.033B 62.63
AtriCure (ATRC) United States $1.027B 0.00
Cerus (CERS) United States $0.973B 0.00
Omeros (OMER) United States $0.968B 0.00
TG Therapeutics (TGTX) United States $0.952B 0.00
MacroGenics (MGNX) United States $0.938B 0.00
Surmodics (SRDX) United States $0.799B 136.93
LeMaitre Vascular (LMAT) United States $0.713B 41.96
Meridian Bioscience (VIVO) United States $0.671B 23.66
PetIQ (PETQ) United States $0.647B 0.00
Insys Therapeutics (INSY) United States $0.612B 0.00
Lantheus Holdings (LNTH) United States $0.530B 13.85
Evolus (EOLS) United States $0.467B 0.00
Surface Oncology (SURF) United States $0.402B 0.00
Utah Medical Products (UTMD) United States $0.363B 24.05
Cytosorbents (CTSO) United States $0.360B 0.00
Quanterix (QTRX) United States $0.346B 0.00
NanoString Technologies (NSTG) United States $0.321B 0.00
BioLife Solutions (BLFS) United States $0.299B 0.00
Rockwell Medical (RMTI) United States $0.235B 0.00
Chimerix (CMRX) United States $0.220B 0.00
Bovie Medical (BVX) United States $0.171B 0.00
Fonar (FONR) United States $0.169B 10.23
Chembio Diagnostics (CEMI) United States $0.157B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.130B 0.00
Female Health (VERU) United States $0.110B 0.00
Trinity Biotech (TRIB) Ireland $0.104B 31.00
Oramed Pharmaceuticals (ORMP) Israel $0.095B 0.00
United-Guardian (UG) United States $0.088B 20.48
Neurotrope (NTRP) United States $0.081B 0.00
InfuSystems Holdings (INFU) United States $0.075B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.049B 0.00
Capricor Therapeutics (CAPR) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Myomo (MYO) United States $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00